Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages

BACKGROUND: Liposomal drug delivery systems, a promising lipid-based nanoparticle technology, have been known to play significant roles in improving the safety and efficacy of an encapsulated drug. METHODS: Liposomes, prepared using an optimized proliposome method, were used in the present work to...

Full description

Bibliographic Details
Main Authors: Chiong, Hoe Siong, Yong, Yoke Keong, Ahmad, Zuraini, Sulaiman, Mohd Roslan, Zakaria, Zainul Amiruddin, Yuen, Kah Hay, Abdullah, Muhammad Nazrul Hakim
Format: Article
Language:English
Published: Dove Medical Press 2013
Online Access:http://psasir.upm.edu.my/id/eprint/29605/1/Cytoprotective%20and%20enhanced%20anti.pdf
_version_ 1825947544288493568
author Chiong, Hoe Siong
Yong, Yoke Keong
Ahmad, Zuraini
Sulaiman, Mohd Roslan
Zakaria, Zainul Amiruddin
Yuen, Kah Hay
Abdullah, Muhammad Nazrul Hakim
author_facet Chiong, Hoe Siong
Yong, Yoke Keong
Ahmad, Zuraini
Sulaiman, Mohd Roslan
Zakaria, Zainul Amiruddin
Yuen, Kah Hay
Abdullah, Muhammad Nazrul Hakim
author_sort Chiong, Hoe Siong
collection UPM
description BACKGROUND: Liposomal drug delivery systems, a promising lipid-based nanoparticle technology, have been known to play significant roles in improving the safety and efficacy of an encapsulated drug. METHODS: Liposomes, prepared using an optimized proliposome method, were used in the present work to encapsulate piroxicam, a widely prescribed nonsteroidal anti-inflammatory drug. The cytotoxic effects as well as the in vitro efficacy in regulation of inflammatory responses by free-form piroxicam and liposome-encapsulated piroxicam were evaluated using a lipopolysaccharide-sensitive macrophage cell line, RAW 264.7. RESULTS: Cells treated with liposome-encapsulated piroxicam demonstrated higher cell viabilities than those treated with free-form piroxicam. In addition, the liposomal piroxicam formulation resulted in statistically stronger inhibition of pro-inflammatory mediators (ie, nitric oxide, tumor necrosis factor-α, interleukin-1β, and prostaglandin E2) than piroxicam at an equivalent dose. The liposome-encapsulated piroxicam also caused statistically significant production of interleukin-10, an anti-inflammatory cytokine. CONCLUSION: This study affirms the potential of a liposomal piroxicam formulation in reducing cytotoxicity and enhancing anti-inflammatory responses in vitro.
first_indexed 2024-03-06T08:15:00Z
format Article
id upm.eprints-29605
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T08:15:00Z
publishDate 2013
publisher Dove Medical Press
record_format dspace
spelling upm.eprints-296052015-09-11T01:42:15Z http://psasir.upm.edu.my/id/eprint/29605/ Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages Chiong, Hoe Siong Yong, Yoke Keong Ahmad, Zuraini Sulaiman, Mohd Roslan Zakaria, Zainul Amiruddin Yuen, Kah Hay Abdullah, Muhammad Nazrul Hakim BACKGROUND: Liposomal drug delivery systems, a promising lipid-based nanoparticle technology, have been known to play significant roles in improving the safety and efficacy of an encapsulated drug. METHODS: Liposomes, prepared using an optimized proliposome method, were used in the present work to encapsulate piroxicam, a widely prescribed nonsteroidal anti-inflammatory drug. The cytotoxic effects as well as the in vitro efficacy in regulation of inflammatory responses by free-form piroxicam and liposome-encapsulated piroxicam were evaluated using a lipopolysaccharide-sensitive macrophage cell line, RAW 264.7. RESULTS: Cells treated with liposome-encapsulated piroxicam demonstrated higher cell viabilities than those treated with free-form piroxicam. In addition, the liposomal piroxicam formulation resulted in statistically stronger inhibition of pro-inflammatory mediators (ie, nitric oxide, tumor necrosis factor-α, interleukin-1β, and prostaglandin E2) than piroxicam at an equivalent dose. The liposome-encapsulated piroxicam also caused statistically significant production of interleukin-10, an anti-inflammatory cytokine. CONCLUSION: This study affirms the potential of a liposomal piroxicam formulation in reducing cytotoxicity and enhancing anti-inflammatory responses in vitro. Dove Medical Press 2013 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/29605/1/Cytoprotective%20and%20enhanced%20anti.pdf Chiong, Hoe Siong and Yong, Yoke Keong and Ahmad, Zuraini and Sulaiman, Mohd Roslan and Zakaria, Zainul Amiruddin and Yuen, Kah Hay and Abdullah, Muhammad Nazrul Hakim (2013) Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages. International Journal of Nanomedicine, 8 (1). pp. 1245-1255. ISSN 1176-9114; ESSN: 1178-2013 http://www.dovepress.com/cytoprotective-and-enhanced-anti-inflammatory-activities-of-liposomal--peer-reviewed-article-IJN 10.2147/IJN.S42801
spellingShingle Chiong, Hoe Siong
Yong, Yoke Keong
Ahmad, Zuraini
Sulaiman, Mohd Roslan
Zakaria, Zainul Amiruddin
Yuen, Kah Hay
Abdullah, Muhammad Nazrul Hakim
Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
title Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
title_full Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
title_fullStr Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
title_full_unstemmed Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
title_short Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
title_sort cytoprotective and enhanced anti inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide stimulated raw 264 7 macrophages
url http://psasir.upm.edu.my/id/eprint/29605/1/Cytoprotective%20and%20enhanced%20anti.pdf
work_keys_str_mv AT chionghoesiong cytoprotectiveandenhancedantiinflammatoryactivitiesofliposomalpiroxicamformulationinlipopolysaccharidestimulatedraw2647macrophages
AT yongyokekeong cytoprotectiveandenhancedantiinflammatoryactivitiesofliposomalpiroxicamformulationinlipopolysaccharidestimulatedraw2647macrophages
AT ahmadzuraini cytoprotectiveandenhancedantiinflammatoryactivitiesofliposomalpiroxicamformulationinlipopolysaccharidestimulatedraw2647macrophages
AT sulaimanmohdroslan cytoprotectiveandenhancedantiinflammatoryactivitiesofliposomalpiroxicamformulationinlipopolysaccharidestimulatedraw2647macrophages
AT zakariazainulamiruddin cytoprotectiveandenhancedantiinflammatoryactivitiesofliposomalpiroxicamformulationinlipopolysaccharidestimulatedraw2647macrophages
AT yuenkahhay cytoprotectiveandenhancedantiinflammatoryactivitiesofliposomalpiroxicamformulationinlipopolysaccharidestimulatedraw2647macrophages
AT abdullahmuhammadnazrulhakim cytoprotectiveandenhancedantiinflammatoryactivitiesofliposomalpiroxicamformulationinlipopolysaccharidestimulatedraw2647macrophages